title: Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Edelman
authors.forename: Lydia
authors.initials: L
authors.lastname: Hodgson
authors.forename: Xiaofei
authors.initials: X
authors.lastname: Wang
authors.forename: Robert A
authors.initials: RA
authors.lastname: Kratzke
authors.forename: Everett E
authors.initials: EE
authors.lastname: Vokes
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D051546:Cyclooxygenase 2 / Q000032:analysis*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D014408:Biomarkers, Tumor; D051546:Cyclooxygenase 2